RxDoctor Payments Data

Farrukh Chaudhry, MD

Neurocritical Care · Munster, INNPI 1003077900

Payments from drug & device makers

$2,632in general payments, 2019–2025

Across 7 payments — averaging $375.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Irras USA, Inc.$3K
  • AstraZeneca$55
  • Chiesi USA, Inc.$29
  • Novartis$18
  • Otsuka America Pharmaceutical, Inc.$15
  • Tetraphase Pharmaceuticals, Inc.$13

What the payments were for

  • Speaking & faculty fees$2,50195%
  • Food & beverage$1315%

General payments by program year

19
20
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few neurocritical care providers in Indianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$290,547
Medicare patients
521
Services billed
1,729

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium15$37

Paid to pharmacies, not to this prescriber.

Other neurocritical care in Munster

Where these figures come from

Is this you, or does something look wrong? →